These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7480543)

  • 21. Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice.
    Abdel-Salam OM; El-Sayed El-Shamarka M; Salem NA; El-Din M Gaafar A
    EXCLI J; 2012; 11():45-58. PubMed ID: 27366134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds.
    Bruni G; Rennekamp AJ; Velenich A; McCarroll M; Gendelev L; Fertsch E; Taylor J; Lakhani P; Lensen D; Evron T; Lorello PJ; Huang XP; Kolczewski S; Carey G; Caldarone BJ; Prinssen E; Roth BL; Keiser MJ; Peterson RT; Kokel D
    Nat Chem Biol; 2016 Jul; 12(7):559-66. PubMed ID: 27239787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine.
    Kim IH; Rossi MA; Aryal DK; Racz B; Kim N; Uezu A; Wang F; Wetsel WC; Weinberg RJ; Yin H; Soderling SH
    Nat Neurosci; 2015 Jun; 18(6):883-91. PubMed ID: 25938885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evaluation of the tropane analogs of haloperidol.
    Sampson D; Bricker B; Zhu XY; Peprah K; Lamango NS; Setola V; Roth BL; Ablordeppey SY
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4294-7. PubMed ID: 25070422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach.
    Johnson M; Kozielska M; Pilla Reddy V; Vermeulen A; Barton HA; Grimwood S; de Greef R; Groothuis GM; Danhof M; Proost JH
    Pharm Res; 2014 Oct; 31(10):2605-17. PubMed ID: 24792824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the potential of antipsychotic agents to induce catalepsy in rats: assessment of a new, commercially available, semi-automated instrument.
    Bricker B; Sampson D; Ablordeppey SY
    Pharmacol Biochem Behav; 2014 May; 120():109-16. PubMed ID: 24565832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the antipsychotic potential of aqueous fraction of Securinega virosa root bark extract in mice.
    Magaji MG; Mohammed M; Magaji RA; Musa AM; Abdu-Aguye I; Hussaini IM
    Metab Brain Dis; 2014 Mar; 29(1):161-5. PubMed ID: 24445435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain disposition and catalepsy after intranasal delivery of loxapine: role of metabolism in PK/PD of intranasal CNS drugs.
    Wong YC; Zuo Z
    Pharm Res; 2013 Sep; 30(9):2368-84. PubMed ID: 23739987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats.
    Román V; Gyertyán I; Sághy K; Kiss B; Szombathelyi Z
    Psychopharmacology (Berl); 2013 Mar; 226(2):285-93. PubMed ID: 23138433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations.
    Wright JM; Dobosiewicz MR; Clarke PB
    Psychopharmacology (Berl); 2013 Feb; 225(4):853-68. PubMed ID: 23052567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the behavioral and pharmacokinetic profile of SYA013, a homopiperazine analog of haloperidol in rats.
    Bricker B; Jackson T; Boateng B; Zhu XY; Ablordeppey SY
    Pharmacol Biochem Behav; 2012 Aug; 102(2):294-301. PubMed ID: 22588199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis.
    Kohlhaas KL; Bitner RS; Gopalakrishnan M; Rueter LE
    Psychopharmacology (Berl); 2012 Apr; 220(4):823-33. PubMed ID: 22038534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.
    Fink-Jensen A; Schmidt LS; Dencker D; Schülein C; Wess J; Wörtwein G; Woldbye DP
    Eur J Pharmacol; 2011 Apr; 656(1-3):39-44. PubMed ID: 21269601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.
    Digby GJ; Shirey JK; Conn PJ
    Mol Biosyst; 2010 Aug; 6(8):1345-54. PubMed ID: 20582339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients.
    Beninger RJ; Baker TW; Florczynski MM; Banasikowski TJ
    Neurotox Res; 2010 Nov; 18(3-4):229-43. PubMed ID: 20376711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs.
    Ardayfio PA; Leung A; Park J; Hwang DY; Moran-Gates T; Choi YK; Carlezon WA; Tarazi FI; Kim KS
    Neuroscience; 2010 Mar; 166(2):391-6. PubMed ID: 20026251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.
    Frånberg O; Marcus MM; Ivanov V; Schilström B; Shahid M; Svensson TH
    Psychopharmacology (Berl); 2009 Jun; 204(2):251-64. PubMed ID: 19198810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.
    Grauer SM; Graf R; Navarra R; Sung A; Logue SF; Stack G; Huselton C; Liu Z; Comery TA; Marquis KL; Rosenzweig-Lipson S
    Psychopharmacology (Berl); 2009 May; 204(1):37-48. PubMed ID: 19107466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To breed or not to breed? Empirical evaluation of drug effects in adolescent rats.
    Wiley JL; Evans RL
    Int J Dev Neurosci; 2009 Feb; 27(1):9-20. PubMed ID: 19041390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.
    Ablordeppey SY; Altundas R; Bricker B; Zhu XY; Kumar EV; Jackson T; Khan A; Roth BL
    Bioorg Med Chem; 2008 Aug; 16(15):7291-301. PubMed ID: 18595716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.